Martin Daniel C.

Chief Commercial Officer at Deciphera Pharmaceuticals, Inc.

Sold, on record
$2.3M
Dollars the filings state
Form 4 sales
12
Latest Feb 16, 2024
Form 144 notices
1
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Deciphera Pharmaceuticals, Inc.Plan not stated
    Feb 16 2023

    Sold 1,159 shares at $15.10 ($18k)

    Martin Daniel C., Chief Commercial Officer

    Sold 1.9% of holdings ($899k position)58,381 shares left0.9x usual sizeFiling

  2. 2 Form 4 sale Deciphera Pharmaceuticals, Inc.No plan
    Jun 16 +120 days

    Sold 1,238 shares at $14.40 ($18k)

    Martin Daniel C., Chief Commercial Officer

    No 10b5-1 planSold 2.1% of holdings ($859k position)58,413 shares left1x usual sizeFiling

  3. 3 Form 4 sale Deciphera Pharmaceuticals, Inc.No plan
    Oct 30 +136 days

    Sold 1,407 shares at $12.02 ($17k)

    Martin Daniel C., Chief Commercial Officer

    No 10b5-1 planSold 2.2% of holdings ($773k position)62,884 shares left1.1x usual sizeFiling

  4. 4 Form 144 notice Deciphera Pharmaceuticals, Inc.Notice
    Nov 30 +31 days

    Filed to sell 17,801 shares ($224k)

    Martin Daniel C., Officer

    No 10b5-1 plan14x usual sizeFiling

  5. 5 Form 4 sale Deciphera Pharmaceuticals, Inc.Unusual
    Nov 30 same day

    Sold 17,801 shares at $12.57 ($224k)

    Martin Daniel C., Chief Commercial Officer

    No 10b5-1 planSold 28.2% of holdings ($795k position)45,435 shares left14x usual sizeFollows a Form 144Filing

  6. 6 Form 4 sale Deciphera Pharmaceuticals, Inc.No plan
    Dec 13 +13 days

    Sold 1,727 shares at $15.37 ($27k)

    Martin Daniel C., Chief Commercial Officer

    No 10b5-1 planSold 3.4% of holdings ($784k position)49,284 shares left1.3x usual sizeFiling

  7. 7 Form 4 sale Deciphera Pharmaceuticals, Inc.No plan
    Jan 16 +34 days

    Sold 1,624 shares at $14.47 ($23k)

    Martin Daniel C., Chief Commercial Officer

    No 10b5-1 planSold 3.3% of holdings ($713k position)47,660 shares left1.2x usual sizeFiling

  8. 8 Form 4 sale Deciphera Pharmaceuticals, Inc.No plan
    Feb 16 +31 days

    Sold 2,267 shares at $15.62 ($35k)

    Martin Daniel C., Chief Commercial Officer

    No 10b5-1 planSold 4% of holdings ($896k position)55,118 shares left1.6x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (13)

Form 144 notices and Form 4 sales by Martin Daniel C.
Source
Feb 16, 2024Deciphera Pharmaceuticals, Inc.Chief Commercial OfficerForm 4 sale2,267$35k4.0%No planSEC
Jan 16, 2024Deciphera Pharmaceuticals, Inc.Chief Commercial OfficerForm 4 sale1,624$23k3.3%No planSEC
Dec 13, 2023Deciphera Pharmaceuticals, Inc.Chief Commercial OfficerForm 4 sale1,727$27k3.4%No planSEC
Nov 30, 2023Deciphera Pharmaceuticals, Inc.Chief Commercial OfficerForm 4 sale17,801$224k28.2%UnusualSEC
Nov 30, 2023Deciphera Pharmaceuticals, Inc.OfficerForm 144 notice17,801$224kNoticeSEC
Oct 30, 2023Deciphera Pharmaceuticals, Inc.Chief Commercial OfficerForm 4 sale1,407$17k2.2%No planSEC
Jun 16, 2023Deciphera Pharmaceuticals, Inc.Chief Commercial OfficerForm 4 sale1,238$18k2.1%No planSEC
Feb 16, 2023Deciphera Pharmaceuticals, Inc.Chief Commercial OfficerForm 4 sale1,159$18k1.9%Plan not statedSEC
Jan 17, 2023Deciphera Pharmaceuticals, Inc.Chief Commercial OfficerForm 4 sale1,603$34k3.2%Plan not statedSEC
Jun 16, 2022Deciphera Pharmaceuticals, Inc.Chief Commercial OfficerForm 4 sale1,311$14k2.6%Plan not statedSEC
Feb 16, 2022Deciphera Pharmaceuticals, Inc.Chief Commercial OfficerForm 4 sale1,146$10k2.3%Plan not statedSEC
Jan 22, 2020Deciphera Pharmaceuticals, Inc.Chief Commercial OfficerForm 4 sale26,999$1.8M61.4%UnusualSEC
Sep 19, 2019Deciphera Pharmaceuticals, Inc.Chief Commercial OfficerForm 4 sale3,000$107k15.0%Plan not statedSEC